Drug Type Small molecule drug |
Synonyms- |
Action inhibitors, modulators, agonists |
Mechanism CTSH inhibitors(cathepsin H inhibitors), MRP1 modulators(ATP binding cassette subfamily C member 1 modulators), OX1R agonists(Orexin receptor type 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Preclinical | United States | 30 Oct 2025 | |
| Parkinson Disease | Preclinical | Switzerland | 30 Oct 2025 |





